Valneva Q4 EPS $(0.68) Misses $(0.21) Estimate, Sales $55.516M Miss $56.190M Estimate

3/18/2026
Impact: -75
Healthcare

Valneva (NASDAQ: VALN) reported a Q4 loss of $(0.68) per share, significantly missing the analyst estimate of $(0.21) by 221.43%, and representing a 25% increase in losses compared to $(0.54) per share from the same period last year. The company's quarterly sales were $55.516 million, falling short of the $56.190 million estimate by 1.20%, and reflecting a 1.75% decrease from $56.504 million in the previous year.

AI summary, not financial advice

Share: